Thyroid Health: An Evidence-Based Guide to Reading Your Labs and Treating Thyroid Disease

The thyroid is one of the most over-blamed and over-treated glands in medicine — and also one of the most genuinely important. Here is an honest map of how to read your thyroid labs, when treatment truly helps, when it quietly harms, and how to tell real thyroid disease from the wellness industry’s favorite scapegoat.

Fatigue, weight gain, brain fog, cold hands, thinning hair, low mood — the symptoms blamed on the thyroid are so broad that almost anyone can find themselves in the list, which is exactly why the thyroid has become the wellness world’s favorite explanation for feeling unwell. Sometimes it truly is the answer: real hypothyroidism is common, under-recognized in some, and genuinely transformative to treat. But just as often the thyroid is blamed when the labs are normal, leading to unnecessary prescriptions, escalating doses, and a class of “thyroid optimization” that can tip a healthy person into a genuinely dangerous overtreated state — thinning bones, a racing or fibrillating heart, and anxiety. This review explains how to actually read a thyroid panel, categorizes the major treatment strategies by how strong the evidence is, and is honest about both sides of the ledger: the person who needs treatment and isn’t getting it, and the person who is being treated for a thyroid that was never the problem. Done correctly and guided by a physician, thyroid care is precise, durable, and life-changing. Done by algorithm or supplement label, it is one of the easier ways to be harmed while believing you’re being optimized.

---

How to Actually Read Your Thyroid Labs

The thyroid runs on a feedback loop. The pituitary gland in your brain releases TSH (thyroid-stimulating hormone) to tell the thyroid how hard to work; the thyroid responds by making mostly T4 (a storage form) and a little T3 (the active hormone), and the body converts T4 into T3 in the tissues as needed. The counter-intuitive key to the whole system: when the thyroid is underactive, TSH goes UP (the brain is shouting louder), and when the thyroid is overactive, TSH goes DOWN. That inverse relationship trips up almost everyone reading their own results for the first time.

Two principles separate careful interpretation from lab-chasing. First, TSH is the anchor: for screening and for monitoring treatment, a properly measured TSH (ideally consistent, and interpreted against a reference range that shifts with age and pregnancy) tells you more than any downstream number. Second, a mildly abnormal TSH is a question, not a diagnosis — it should be repeated, because TSH fluctuates with time of day, acute illness, and stress, and a single borderline value often normalizes on its own. Chasing free T3 or reverse T3 to arbitrary “optimal” targets — a hallmark of the optimization industry — is where good intentions become overtreatment.

---

Hypothyroidism: The Proven Foundation

Established · levothyroxine is first-line

When the thyroid genuinely underperforms — a clearly high TSH with a low free T4, called overt hypothyroidism, most often from the autoimmune condition Hashimoto’s — treatment is one of the clearest wins in medicine. The American Thyroid Association is unambiguous: levothyroxine (synthetic T4) is the standard of care, a single daily tablet that restores the hormone the body can no longer make, taken on an empty stomach and re-checked with a TSH about 6–8 weeks after any dose change. Dosed correctly, it resolves the fatigue, cold intolerance, constipation, and cognitive slowing of a truly underactive thyroid, and it is safe to take for life.

The subclinical trap: a mildly high TSH

The harder and more common situation is subclinical hypothyroidism — a mildly elevated TSH with a still-normal free T4. It is tempting to treat the number, but the best evidence urges caution. In the landmark TRUST trial, 737 older adults with subclinical hypothyroidism were randomized to levothyroxine or placebo; the drug did not improve hypothyroid symptoms or tiredness at all. A BMJ Rapid Recommendation went further, advising against routine thyroid hormone for most adults with subclinical hypothyroidism. The evidence-based approach is to repeat the test, look at antibodies and symptoms, and reserve treatment for higher TSH levels, pregnancy or fertility plans, or clearly attributable symptoms — not to medicate a borderline value on reflex.

---

Beyond Levothyroxine: T3, Combination & Desiccated Thyroid

Emerging & selective · where judgment matters most

A vocal group of patients feel unwell on levothyroxine despite a normal TSH, and this is the space where the optimization industry lives — promising that adding T3 (liothyronine) or switching to desiccated thyroid extract (NDT, e.g., Armour, a pig-derived product containing both T4 and T3) will restore what T4 alone cannot. The honest evidence is nuanced. Systematic reviews and meta-analyses, including a 2024 analysis, have not shown that combination T4/T3 therapy or desiccated thyroid is reliably superior to levothyroxine for quality of life or symptoms — even as some individual patients report a subjective preference for it. Accordingly, the ATA guidelines keep levothyroxine as first-line and do not endorse routine combination or NDT therapy.

That does not mean the patient’s experience is imaginary — genetics in T4-to-T3 conversion may matter for a subset, and a carefully monitored trial of combination therapy is a legitimate, individualized option in the hands of a physician. But two cautions are essential. First, desiccated thyroid delivers a relatively high, less predictable dose of T3, which can push levels too high. Second, the goal is never to suppress TSH to feel a stimulant-like lift; that is not optimization, it is subclinical hyperthyroidism — and it carries the very real risks covered next. This is precisely the terrain where “more T3” sold as vitality quietly becomes harm.

---

Hyperthyroidism & Thyroid Nodules

Established treatment · and a caution about overdiagnosis

An overactive thyroid (hyperthyroidism) — most often from Graves’ disease, sometimes from a “hot” nodule — is the mirror image: a suppressed TSH with high thyroid hormone, causing racing heart, weight loss, tremor, anxiety, and heat intolerance. It is important to treat because, left unchecked, it drives atrial fibrillation and bone loss. The ATA’s guidelines lay out three proven paths — antithyroid medication (methimazole), radioactive iodine, and surgery — each with trade-offs, chosen through shared decision-making. This is real disease with real, effective treatment; the same overactivity a wellness protocol might accidentally induce is one we work hard to fix when it occurs naturally.

Nodules and the thyroid-cancer overdiagnosis epidemic

Thyroid nodules are extraordinarily common — found in a large share of adults if you scan enough necks — and the overwhelming majority are benign. As neck imaging exploded, so did the detection of tiny, low-risk papillary thyroid cancers, producing a genuine overdiagnosis epidemic: far more cancers found and removed, with little change in the number of people dying from thyroid cancer. The evidence-based response has been a shift toward active surveillance — carefully watching very small, low-risk papillary microcarcinomas rather than rushing every one to surgery — now a validated, guideline-supported option. It is a powerful reminder that finding more is not the same as helping more, and that the reflex to treat every abnormality can itself be the harm.

---

Nutrition, Autoimmunity & Supplements

Selective · correct real deficiencies, ignore the hype

The thyroid needs iodine to make hormone, and severe iodine deficiency is a leading cause of thyroid disease worldwide — but in iodine-sufficient countries like the United States, more is not better. Excess iodine (from kelp, high-dose supplements, or “thyroid support” blends) can actually trigger both hyper- and hypothyroidism, especially in people with underlying autoimmune thyroid disease. This is a genuine risk hiding inside products marketed as thyroid-friendly, and some “glandular” supplements have even been found to contain actual thyroid hormone — an unlabeled, unmonitored drug.

Selenium in Hashimoto’s: promising, limited

Selenium is the one supplement with a real, if modest, evidence base in autoimmune thyroid disease. In people with Hashimoto’s, selenium supplementation can modestly lower thyroid antibody levels in several randomized trials — but the reviews are candid that this has not been shown to change the outcomes that matter (whether people feel better, avoid progression, or reduce medication needs). It is reasonable in selected patients under guidance; it is not a cure, and megadosing carries its own toxicity. As with the rest of thyroid nutrition, the evidence-based move is to correct a documented problem — not to supplement a healthy gland on the promise of “support.”

---

The Long View

The most-prescribed pill in America — and a lesson in the harm of overtreatment

Levothyroxine is, year after year, among the most prescribed medications in the United States — taken by more than 20 million Americans. That ubiquity is a double-edged sword. It reflects how common and treatable real hypothyroidism is; it also reflects how easily the diagnosis is applied. Researchers at Yale and elsewhere estimate that a large share of people on thyroid hormone — on the order of tens of millions across similar analyses — may have started it for a borderline lab or nonspecific symptoms and may not need it, or may be taking more than they should. The thyroid, in other words, is not only under-treated in some; it is over-treated in many.

The harm of overtreatment is not hypothetical. Pushing thyroid hormone too high — whether by over-dosing levothyroxine, layering on unnecessary T3, or chasing a “suppressed” TSH in the name of energy or weight loss — produces a state of subclinical hyperthyroidism that is linked in large studies to atrial fibrillation, accelerated bone loss and fractures, and cardiovascular strain, particularly in older adults. This is the quiet danger of the wellness model: a person who felt tired is given a hormone that makes them briefly feel “energized,” the dose creeps upward as tolerance builds, the TSH is driven to zero, and months later the cost arrives as palpitations or a fragility fracture. The symptom that started it all — fatigue — was rarely the thyroid to begin with.

That is the entire argument for an evidence-based physician, and it is not a marketing line — it is a function. A physician confirms a borderline TSH before committing you to a lifelong drug, and looks for the sleep, iron, mood, and metabolic causes that masquerade as “low thyroid.” A physician treats overt disease decisively, watches subclinical disease patiently, and refuses to suppress your TSH to chase a number. A physician recognizes the tiny cancer that can be safely watched, the excess iodine hiding in a supplement, and the T3 dose that is buying today’s energy with tomorrow’s bone density. Used this way, thyroid care is genuinely powerful — restoring people with real disease to full function, and protecting the many who are told the thyroid is their problem when it isn’t.

So where does that leave a thoughtful patient? Not dismissive of the thyroid, and not credulous about it. Real thyroid disease deserves real, decisive treatment; a normal thyroid deserves to be left alone. The difference between a result and a regret is almost always whether someone with medical judgment — not an algorithm optimizing for a refill or a panel of “optimal ranges” — decided whether your thyroid was truly the problem, and what, if anything, to do about it. That is the whole project: not the average lab value, but the actual patient.

---

If You’re Considering Thyroid Testing or Treatment